Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • Katsuyuki Hotta
2020
Open Access
1 Citation (Scopus)

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer

Nakagawa, K., Hida, T., Nokihara, H., Morise, M., Azuma, K., Kim, Y. H., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Kumagai, T., Hotta, K., Watanabe, S., Goto, K., Satouchi, M., Kozuki, T., Koyama, R., Mitsudomi, T., Yamamoto, N., Asakawa, T. & 3 others, Hayashi, M., Hasegawa, W. & Tamura, T., Jan 1 2020, In : Lung cancer (Amsterdam, Netherlands). 139, p. 195-199 5 p.

Research output: Contribution to journalArticle

Open Access

Pilot evaluation of a HER2 testing in non-small-cell lung cancer

Hotta, K., Yanai, H., Ohashi, K., Ninomiya, K., Nakashima, H., Kayatani, H., Takata, M. & Kiura, K., Jun 1 2020, In : Journal of Clinical Pathology. 73, 6, p. 353-357 5 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Successful re-administration of osimertinib in osimertinib-induced interstitial lung disease with an organizing pneumonia pattern: A case report and literature review

Itano, J., Higo, H., Ohashi, K., Makimoto, G., Nishii, K., Hotta, K., Miyahara, N., Maeda, Y. & Kiura, K., Mar 15 2020, In : Internal Medicine. 59, 6, p. 823-828 6 p.

Research output: Contribution to journalReview article

Open Access

The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Ichihara, E., Harada, D., Inoue, K., Sato, K., Hosokawa, S., Kishino, D., Watanabe, K., Ochi, N., Oda, N., Hara, N., Hotta, K., Maeda, Y. & Kiura, K., Jan 2020, In : Lung Cancer. 139, p. 140-145 6 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
2019

A long-term response to nivolumab in a case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages

Watanabe, H., Ohashi, K., Nishii, K., Seike, K., Makimoto, G., Hotta, K., Maeda, Y. & Kiura, K., Jan 1 2019, In : Internal Medicine. 58, 20, p. 3033-3037 5 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement

Harada, D., Kozuki, T., Nogami, N., Bessho, A., Hosokawa, S., Fukamatsu, N., Hotta, K., Oohashi, K., Kubo, T., Yoshioka, H., Yokoyama, T., Sone, N., Kuyama, S., Kudo, K., Yasugi, M., Takigawa, N., Oze, I. & Kiura, K., Jan 1 2019, In : Asia-Pacific Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Open Access

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Ninomiya, K., Hata, T., Yoshioka, H., Ohashi, K., Bessho, A., Hosokawa, S., Ishikawa, N., Yamasaki, M., Shibayama, T., Aoe, K., Kozuki, T., Harita, S., Ueda, Y., Murakami, T., Fujimoto, N., Yanai, H., Toyooka, S., Takata, M., Hotta, K., Kiura, K. & 108 others, Gemba, K., Ikeda, G., Yasugi, M., Kurimoto, E., Nakano, K., Moritaka, T., Inoue, K., Miyoshi, S., Hamaguchi, N., Ito, R., Sano, Y., Takata, I., Mitani, A., Nishisaka, T., Shoda, H., Nishida, A., Tamamoto, S., Fujitaka, K., Masuda, T., Miyamoto, S., Hattori, N., Sugimoto, K., Fujii, S., Ueda, Y., Sakugawa, M., Fukamatsu, N., Ogata, Y., Bandoh, S., Kanaji, N., Takigawa, N., Yamane, H., Ochi, N., Honda, Y., Oka, M., Kittaka, M., Kubota, T., Yokoyama, A., Yokoyama, T., Sato, E., Shiota, Y., Horita, N., Kanematsu, T., Awaya, Y., Nakamasu, A., Murakami, I., Kuyama, S., Kudo, K., Tamura, T., Umeno, T., Morichika, D., Fujiwara, K., Sato, K., Harada, D., Nogami, N., Nishii, K., Fuchimoto, Y., Kishimoto, T., Kawai, H., Watanabe, K., Tokumo, K., Isobe, T., Tsubata, Y., Inoue, M., Ichikawa, H., Nishioka, Y., Hanibuchi, M., Goto, H., Sumikawa, T., Kodani, M., Suyama, H., Makino, H., Kinosita, N., Shimizu, E., Obata, H., Ikegami, H., Chikamori, K., Maeda, T., Kishino, T., Kamei, H., Ueoka, H., Kunihiro, Y., Kobayashi, T., Ueda, K., Hayashi, M., Kamiya, M., Murakami, J., Sato, A., Ichihara, E., Kubo, T., Ninomiya, T., Hirata, T., Minami, D., Kato, Y., Higo, H., Makimoto, G., Toyota, Y., Oda, N., Nakanishi, M., Kayatani, H., Senoo, S., Kano, H., Watanabe, H., Ando, T., Nakasuka, T., Hara, N., Itano, J., Nakashima, H. & Tabata, M., Aug 2019, In : Chest. 156, 2, p. 357-366 10 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
Open Access
1 Citation (Scopus)

Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities

Higo, H., Kubo, T., Makimoto, S., Makimoto, G., Ihara, H., Masaoka, Y., Ninomiya, T., Ichihara, E., Ohashi, K., Sato, A., Hotta, K., Tabata, M., Takigawa, N., Maeda, Y. & Kiura, K., Jan 1 2019, In : Japanese journal of clinical oncology. 49, 5, p. 458-464 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Corrigendum to “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan” [Lung Cancer, 129 (March)(2019)55–62](S0169500219300212)(10.1016/j.lungcan.2019.01.005)

Watanabe, S., Yoshioka, H., Sakai, H., Hotta, K., Takenoyama, M., Yamada, K., Sugawara, S., Takiguchi, Y., Hosomi, Y., Tomii, K., Niho, S., Yamamoto, N., Nishio, M., Ohe, Y., Kato, T., Takahashi, T., Kamada, A., Suzukawa, K., Omori, Y., Enatsu, S. & 2 others, Nakagawa, K. & Tamura, T., Jun 2019, In : Lung Cancer. 132, p. 157-158 2 p.

Research output: Contribution to journalComment/debate

Open Access
39 Citations (Scopus)

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Higo, H., Ohashi, K., Makimoto, G., Nishii, K., Kudo, K., Kayatani, H., Watanabe, H., Kano, H., Ninomiya, K., Hotta, K., Maeda, Y. & Kiura, K., Oct 2019, In : Lung Cancer. 136, p. 86-93 8 p.

Research output: Contribution to journalArticle

Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial

Soh, J., Toyooka, S., Okumura, N., Nakamura, H., Nakata, M., Yamashita, M., Sakamoto, J., Aoe, M., Hotta, K., Morita, S. & Date, H., Nov 1 2019, In : International Journal of Clinical Oncology. 24, 11, p. 1367-1376 10 p.

Research output: Contribution to journalArticle

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan

Watanabe, S., Yoshioka, H., Sakai, H., Hotta, K., Takenoyama, M., Yamada, K., Sugawara, S., Takiguchi, Y., Hosomi, Y., Tomii, K., Niho, S., Yamamoto, N., Nishio, M., Ohe, Y., Kato, T., Takahashi, T., Kamada, A., Suzukawa, K., Omori, Y., Enatsu, S. & 2 others, Nakagawa, K. & Tamura, T., Mar 2019, In : Lung Cancer. 129, p. 55-62 8 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Nivolumab for the treatment of unresectable pleural mesothelioma

Hotta, K., Fujimoto, N., Kozuki, T., Aoe, K. & Kiura, K., Jan 1 2019, (Accepted/In press) In : Expert Opinion on Biological Therapy.

Research output: Contribution to journalArticle

Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Makimoto, G., Hotta, K., Oze, I., Ninomiya, K., Nakanishi, M., Hara, N., Kano, H., Watanabe, H., Hata, Y., Nishii, K., Nakasuka, T., Itano, J., Ninomiya, T., Kubo, T., Ohashi, K., Ichihara, E., Minami, D., Sato, A., Tabata, M., Maeda, Y. & 1 others, Kiura, K., Jan 1 2019, (Accepted/In press) In : Acta Oncologica.

Research output: Contribution to journalLetter

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Mok, T. S. K., Wu, Y. L., Kudaba, I., Kowalski, D. M., Cho, B. C., Turna, H. Z., Castro, G., Srimuninnimit, V., Laktionov, K. K., Bondarenko, I., Kubota, K., Lubiniecki, G. M., Zhang, J., Kush, D., Lopes, G., Gomez Aubin, G., Fein, L., Kaen, D., Kowalyszyn, R., Lerzo, G. & 236 others, Martinengo, G., Molina, M., Richardet, E., Picon, P., Varela, M., Zarba, J. J., de Azevedo, S. J., Barrios, C. H., Beato, C., Cerny, C. A. S., De Marchi, P. R. M., Fernandes, G., Franke, F. A., Freitas, H., Girotto, G., Lopes, V., Santos, L., Costa, M. A., Shimada, A. K., Smaletz, O., Soares, J. P. H., Victorino, A. P., Ferreira, C., Koleva, M., Koynov, K., Micheva, R., Deliverski, T., Milanova, Z., Doganov, B., Cheng, S., De Angelis, F., Speranza, G., Juergens, R. A., Ksienski, D., Fenton, D., Aren, O., Caglevic, C., Galindo, H., Rey, F., Chang, J., Chen, G., Chen, X., Ouyang, X., Cheng, Y., Ding, Z., Hou, M., Fan, Y., Feng, J., He, J., He, Y., Hu, Y., Li, W., Liu, X., Liu, Z., Lu, S., Qin, S., Tang, Q., Wang, B., Wang, K., Zhang, L., Zhang, X., Zhao, J., Wang, J., Zhou, C., Zhou, J., Zhou, Q., Wu, Y., Cardona, A., Duarte, R., Gomez Wolff, L., Zambrano, A., Vallejo, M., Havel, L., Kolek, V., Kolman, P., Koubkova, L., Petruzelka, L., Popelkova, P., Roubec, J., Vanasek, J., Vlasek, T., Jaal, J., Kuusk, G., Avendano, O., Castro, H., Lopez, K., Sandoval, M., Ho, C. M. J., Lo, S. H., Laczo, I., Piko, B., Ostoros, G., Aoe, K., Fujisaka, Y., Hirashima, T., Horiike, A., Hosomi, Y., Hotta, K., Ichiki, M., Imamura, F., Iwamoto, Y., Kasahara, K., Katakami, N., Kato, T., Murakami, S., Kawaguchi, T., Kishi, K., Kubota, K., Kurata, T., Torii, Y., Nakahara, Y., Nishimura, T., Ohira, T., Saka, H., Sawa, T., Seki, N., Sugawara, S., Takahashi, K., Takigawa, N., Tanaka, H., Yamada, K., Yokoyama, T., Yokoyama, T., Yoshioka, H., Kudaba, I., Purkalne, G., Stara, Z., Cesas, A., Cicenas, S., Zemaitis, M., How, S. H., Liam, C. K., Ong, C. K., Tho, L. M., Arrieta Rodriguez, O., de The Bustamante Valles, F., Hernandez Hernandez, C., Mas, L., Vera, L., Salas, J., Tejada, H., Edusma-Dy, R., Galvez, C., Ladrera, G. E. I., Tan Chun Bing, J., Jassem, J., Kalinka-Warzocha, E., Karaszewska, B., Kazarnowicz, A., Kowalski, D., Lesniewski Kmak, K., Ramlau, R., Araujo, A., Barata, F., Gil, N., Hespanhol, V., Alexandru, A., Dediu, M., Cherciu, N., Ciurescu, D., Ganea, D., Miron, L., Sirbu, D., Turdean, M., Emelyanov, S., Karaseva, N., Kuzina, L., Lazarev, S., Lifirenko, I., Bolotina, L., Lipatov, O., Ovchinnikova, E., Matrosova, M., Alyasova, A., Poltoratsky, A., Taranov, P., Zarubenkov, O., Cohen, G., Dreosti, L., Seolwane, F., Hall, J., Hart, G., Jordaan, C., Buddu, S., Botha, M., Landers, G., Rappaport, B., Ruff, P., Shepherd, L., Szpak, W., Ahn, M. J., Cho, B. C., Kim, J. H., Bergstrom, P., Ohman, R., Griph, H., Betticher, D., Ochsenbein, A., Zippelius, A., Chan, G. C., Chiu, C. H., Hsia, T. C., Su, W. C., Yang, C. H., Ativitavas, T., Danchaivijitr, P., Srimuninnimit, V., Seetalarom, K., Sookprasert, A., Sriuranpong, V., Altundag, O., Cay Senler, F., Erman, M., Goksel, T., Goker, E., Ozyilkan, O., Seker, M., Gumus, M., Turna, H., Yumuk, F., Adamchuk, G., Bondarenko, I., Ivashchuk, O., Ponomarova, O., Rusyn, A., Shevnya, S., Shparyk, Y., Sinielnikov, I., Andrusenko, O., Trukhyn, D., Ursol, G., Vynnychenko, I., Nguyen, T. Q., Pham, X. D., Castro, G. & Kubota, K., May 4 2019, In : The Lancet. 393, 10183, p. 1819-1830 12 p.

Research output: Contribution to journalArticle

250 Citations (Scopus)

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

Ninomiya, T., Ishikawa, N., Inoue, K., Kubo, T., Yasugi, M., Shibayama, T., Maeda, T., Fujitaka, K., Kodani, M., Yokoyama, T., Kuyama, S., Ochi, N., Ueda, Y., Miyoshi, S., Kozuki, T., Amano, Y., Kubota, T., Sugimoto, K., Bessho, A., Ishii, T. & 4 others, Watanabe, K., Oze, I., Hotta, K. & Kiura, K., Mar 2019, In : Clinical Lung Cancer. 20, 2, p. 134-138 5 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Physician requests by patients with malignant pleural mesothelioma in Japan

Nagamatsu, Y., Oze, I., Aoe, K., Hotta, K., Kato, K., Nakagawa, J., Hara, K., Kishimoto, T. & Fujimoto, N., Apr 25 2019, In : BMC cancer. 19, 1, 383.

Research output: Contribution to journalArticle

Open Access

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Nakagawa, K., Garon, E. B., Seto, T., Nishio, M., Ponce Aix, S., Paz-Ares, L., Chiu, C. H., Park, K., Novello, S., Nadal, E., Imamura, F., Yoh, K., Shih, J. Y., Au, K. H., Moro-Sibilot, D., Enatsu, S., Zimmermann, A., Frimodt-Moller, B., Visseren-Grul, C., Reck, M. & 96 others, Chu, Q., Cortot, A., Pujol, J. L., Fabre, E., Lamour, C., Bischoff, H., Kollmeier, J., Kimmich, M., Engel-Riedel, W., Hammerschmidt, S., Schütte, W., Syrigos, K., Ho, J. C. M., Au, K. H., Ardizzoni, A., Pasello, G., Gregorc, V., Del Conte, A., Galetta, D., Takahashi, T., Kumagai, T., Hotta, K., Goto, Y., Hosomi, Y., Sakai, H., Takiguchi, Y., Kim, Y. H., Kurata, T., Yamaguchi, H., Daga, H., Okamoto, I., Satouchi, M., Ikeda, S., Kasahara, K., Atagi, S., Azuma, K., Aoe, K., Horio, Y., Yamamoto, N., Tanaka, H., Watanabe, S., Nogami, N., Ozaki, T., Koyama, R., Hirashima, T., Kaneda, H., Tomii, K., Fujita, Y., Seike, M., Nishimura, N., Kato, T., Ichiki, M., Saka, H., Hirano, K., Nakahara, Y., Sugawara, S., Kim, S. W., Min, Y. J., Lee, H. W., Kang, J. H., An, H. J., Lee, K. H., Kim, J. S., Lee, G. W., Lee, S. Y., Alexandru, A., Udrea, A. A., Juan-Vidal, Ó., Nadal-Alforja, E., Gil-Bazo, I., Ponce-Aix, S., Rubio-Viqueira, B., Alonso Garcia, M., Felip Font, E., Fuentes Pradera, J., Coves Sarto, J., Lin, M. C., Su, W. C., Hsia, T. C., Chang, G. C., Wei, Y. F., Su, J., Cicin, I., Goksel, T., Harputluoglu, H., Ozyilkan, O., Henning, I., Popat, S., Hatcher, O., Mileham, K., Acoba, J., Garon, E., Jung, G., Raj, M., Martin, W. & Dakhil, S., Dec 2019, In : The Lancet Oncology. 20, 12, p. 1655-1669 15 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden

Makimoto, G., Ohashi, K., Tomida, S., Nishii, K., Matsubara, T., Kayatani, H., Higo, H., Ninomiya, K., Sato, A., Watanabe, H., Kano, H., Ninomiya, T., Kubo, T., Rai, K., Ichihara, E., Hotta, K., Tabata, M., Toyooka, S., Takata, M., Maeda, Y. & 1 others, Kiura, K., Jan 1 2019, (Accepted/In press) In : Journal of Thoracic Oncology.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Senoo, S., Ninomiya, T., Makimoto, G., Nishii, K., Kano, H., Watanabe, H., Hata, Y., Kubo, T., Tanaka, T., Hotta, K., Maeda, Y. & Kiura, K., Apr 1 2019, In : Internal medicine (Tokyo, Japan). 58, 7, p. 985-989 5 p.

Research output: Contribution to journalArticle

Open Access
2 Citations (Scopus)
4 Citations (Scopus)

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan

Senoo, S., Ninomiya, K., Hotta, K. & Kiura, K., May 15 2019, In : International Journal of Clinical Oncology. 24, 5, p. 461-467 7 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Recent trends in the treatment of unresectable stage III non-small-cell lung cancer

Makimoto, G., Hotta, K. & Kiura, K., Jan 1 2019, In : Respiratory Investigation.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Revision of lung cancer clinical practice guidelines ―focusing on the area of pharmacotherapy―

Hotta, K., Nov 25 2019, In : Japanese Journal of Lung Cancer. 59, p. 1076-1078 3 p.

Research output: Contribution to journalComment/debate

Successful Treatment of Metastatic Urothelial Carcinoma after Accurate Diagnosis by Immunohistochemistry

Makimoto, G., Nishimori, H., Kondo, R., Yanai, H., Sugimoto, M., Oda, N., Kubo, T., Hotta, K., Tabata, M., Kiura, K. & Maeda, Y., Jun 1 2019, In : Acta medica Okayama. 73, 3, p. 279-284 6 p.

Research output: Contribution to journalArticle

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Watanabe, H., Kubo, T., Ninomiya, K., Kudo, K., Minami, D., Murakami, E., Ochi, N., Ninomiya, T., Harada, D., Yasugi, M., Ichihara, E., Ohashi, K., Fujiwara, K., Hotta, K., Tabata, M., Maeda, Y. & Kiura, K., Aug 1 2019, In : Japanese journal of clinical oncology. 49, 8, p. 762-765 4 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Updated analysis of KEYNOTE-024: Pembrolizumab versus platinum-based chemotherapy for advanced non–small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater

Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csoszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., O’Brien, M., Rao, S., Hotta, K., Vandormael, K., Riccio, A., Yang, J., Catherine Pietanza, M. & Brahmer, J. R., Jan 1 2019, In : Journal of Clinical Oncology. 37, 7, p. 537-546 10 p.

Research output: Contribution to journalArticle

139 Citations (Scopus)
2018

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer

Toyooka, S., Okumura, N., Nakamura, H., Nakata, M., Yamashita, M., Tada, H., Kajiwara, S., Watanabe, N., Okada, M., Sakamoto, J., Aoe, M., Soh, J., Miyoshi, S., Hotta, K., Matsuo, K. & Date, H., May 2018, In : Journal of Thoracic Oncology. 13, 5, p. 699-706 8 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

A phase II trial of EGFR-TKI readministration with afatinib in advanced non-small-cell lung cancer harboring a sensitive non-T790M EGFR mutation: Okayama Lung Cancer Study Group trial 1403

Oda, N., Hotta, K., Ninomiya, K., Minami, D., Ichihara, E., Murakami, T., Yokoyama, T., Ichikawa, H., Chikamori, K., Takigawa, N., Ochi, N., Harita, S., Maeda, Y. & Kiura, K., Jan 1 2018, (Accepted/In press) In : Cancer Chemotherapy and Pharmacology.

Research output: Contribution to journalArticle

5 Citations (Scopus)

A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol

Fujimoto, N., Aoe, K., Kozuki, T., Oze, I., Kato, K., Kishimoto, T. & Hotta, K., Jan 1 2018, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

11 Citations (Scopus)

A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404

Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fukamatsu, N., Fujimoto, N., Aoe, K., Shibayama, T., Sugimoto, K., Takigawa, N., Hotta, K. & Kiura, K., Jan 2018, In : Lung Cancer. 115, p. 103-108 6 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)
6 Citations (Scopus)

Combined effect of cabozantinib and gefitinib in crizotinib-resistant lung tumors harboring ROS1 fusions

Kato, Y., Ninomiya, K., Ohashi, K., Tomida, S., Makimoto, G., Watanabe, H., Kudo, K., Matsumoto, S., Umemura, S., Goto, K., Ichihara, E., Ninomiya, T., Kubo, T., Sato, A., Hotta, K., Tabata, M., Toyooka, S., Maeda, Y. & Kiura, K., Oct 2018, In : Cancer Science. 109, 10, p. 3149-3158 10 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing

Iwama, E., Sakai, K., Azuma, K., Harada, D., Nosaki, K., Hotta, K., Nishio, M., Kurata, T., Fukuhara, T., Akamatsu, H., Goto, K., Shimose, T., Kishimoto, J., Nakanishi, Y., Nishio, K. & Okamoto, I., Dec 2018, In : Cancer Science. 109, 12, p. 3921-3933 13 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Immune checkpoint inhibitor efficacy and safety in elderly non-small cell lung cancer patients

Kubo, T., Watanabe, H., Ninomiya, K., Kudo, K., Minami, D., Murakami, E., Ochi, N., Ninomiya, T., Harada, D., Yasugi, M., Ichihara, E., Ohashi, K., Fujiwara, K., Hotta, K., Tabata, M., Maeda, Y. & Kiura, K., Oct 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. viii533-viii534

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)
15 Citations (Scopus)

Pembrolizumab for the first-line treatment of non-small cell lung cancer

Ninomiya, K. & Hotta, K., Oct 3 2018, In : Expert Opinion on Biological Therapy. 18, 10, p. 1015-1021 7 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Phase II study of ceritinib in alectinib-pretreated patients with anaplastic lymphoma kinase-rearranged metastatic non-small-cell lung cancer in Japan: ASCEND-9

Hida, T., Seto, T., Horinouchi, H., Maemondo, M., Takeda, M., Hotta, K., Hirai, F., Kim, Y. H., Matsumoto, S., Ito, M., Ayukawa, K., Tokushige, K., Yonemura, M., Mitsudomi, T. & Nishio, M., Sep 1 2018, In : Cancer Science. 109, 9, p. 2863-2872 10 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)
11 Citations (Scopus)

Quality of life of survivors of malignant pleural mesothelioma in Japan: A cross sectional study

Nagamatsu, Y., Oze, I., Aoe, K., Hotta, K., Kato, K., Nakagawa, J., Hara, K., Kishimoto, T. & Fujimoto, N., Mar 27 2018, In : BMC Cancer. 18, 1, 350.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery

Makimoto, G., Kubo, T., Oze, I., Ohashi, K., Hotta, K., Tabata, M., Soh, J., Toyooka, S., Katsui, K., Takigawa, N., Tanimoto, M. & Kiura, K., Mar 1 2018, In : Japanese journal of clinical oncology. 48, 3, p. 287-290 4 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
6 Citations (Scopus)